GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch
GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward…
OSE Immunotherapeutics met jour linformation sur les procdures en cours
OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2,…
OPTO Miner launches new green cloud mining platform application
Seattle, Washington, July 01, 2025 (GLOBE NEWSWIRE) -- Against the backdrop of…
FINDMINING launches a new free cloud mining platform to help investors seize new opportunities in the Bitcoin and Litecoin bull market
London, UK, July 01, 2025 (GLOBE NEWSWIRE) -- As Bitcoin (BTC) breaks…
DRML Miner Launches Innovative USDC Cloud Mining Platform: Experience Daily Rewards and Referral Bonuses at Zero Cost
New York, NY, July 01, 2025 (GLOBE NEWSWIRE) -- A Trusted Gateway…
Processa Pharmaceuticals Provides Portfolio and Business Update
Signed binding term sheet granting Intact Therapeutics an exclusive option to license…
Inmagene Doses First Patient in the ADAPTIVE Phase 2b Trial of IMG-007, a Nondepleting Anti-OX40 mAb with an Extended Half-life, in Patients with Moderate-to-Severe Atopic Dermatitis
July 01, 2025 09:00 ET | Source: Inmagene Biopharmaceuticals The ADAPTIVE Phase…
Visory Health Wins Gold at the 2025 Digital Health Awards
ESTERO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Visory Health, a leading…
Acceleware Announces Non-Brokered Private Placement of Units and Shares for Debt Transactions
CALGARY, Alberta, June 30, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or…
Acesis Biomed Secures Patents Advancing Testosterone-Inducing Drug Development
Centennial, Colorado, June 30, 2025 (GLOBE NEWSWIRE) -- Acesis Holdings Corporation (“Acesis Biomed”),…
